title: Patents or patients: who loses?
abstract: The unprecedented weakening of patent rights in the United States undermines necessary incentives for the discovery and development of innovative medicines.
authors.forename: Joanna
authors.initials: J
authors.lastname: Brougher
authors.affiliation: Nutter McClennen &Fish LLP, Boston, Massachusetts, USA.
authors.forename: Konstantin M
authors.initials: KM
authors.lastname: Linnik
mesh_terms: D004358:Drug Therapy; D010330:Patents as Topic; D028701:Patient Rights; D014481:United States